BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27269133)

  • 1. Prognostic value of posttreatment neutrophil-lymphocyte ratio in head and neck squamous cell carcinoma treated by chemoradiotherapy.
    Kim DY; Kim IS; Park SG; Kim H; Choi YJ; Seol YM
    Auris Nasus Larynx; 2017 Apr; 44(2):199-204. PubMed ID: 27269133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy.
    Moon H; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Radiother Oncol; 2016 Feb; 118(2):330-4. PubMed ID: 26653356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy.
    Chandrasekara S; Davis S; Thomson P; Haydon A
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e442-e447. PubMed ID: 29345108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
    Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
    Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen and Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Advanced Hypopharyngeal Squamous Cell Carcinoma.
    Kuwahara T; Takahashi H; Sano D; Matsuoka M; Hyakusoku H; Hatano T; Hiiragi Y; Oridate N
    Anticancer Res; 2018 Sep; 38(9):5321-5330. PubMed ID: 30194184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
    Wu F; Wu LL; Zhu LX
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
    [No Abstract]   [Full Text] [Related]  

  • 7. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
    Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
    Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-treatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy.
    Zeng YC; Chi F; Xing R; Xue M; Wu LN; Tang MY; Wu R
    Jpn J Clin Oncol; 2016 Feb; 46(2):126-31. PubMed ID: 26611205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Zhou XL; Li YQ; Zhu WG; Yu CH; Song YQ; Wang WW; He DC; Tao GZ; Tong YS
    Sci Rep; 2017 Feb; 7():42581. PubMed ID: 28195186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
    Toh E; Wilson J; Sebag-Montefiore D; Botterill I
    Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
    Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic evaluation of neutrophil-to-lymphocyte ratio as prognostic factor in stage III non-small cell lung cancer treated with chemoradiotherapy.
    Palomar-Abril V; Soria-Comes T; Campos ST; Ureste MM; Bosch VG; Maiques ICM
    Clin Transl Oncol; 2020 Dec; 22(12):2333-2340. PubMed ID: 32449125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer.
    Valero C; Pardo L; López M; García J; Camacho M; Quer M; León X
    Head Neck; 2017 Feb; 39(2):219-226. PubMed ID: 27534525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma.
    Chen L; Zeng H; Yang J; Lu Y; Zhang D; Wang J; Kuang C; Zhu S; Wang M; Ma X
    BMC Cancer; 2018 Aug; 18(1):816. PubMed ID: 30103707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: A systematic review and meta-analysis.
    Tham T; Bardash Y; Herman SW; Costantino PD
    Head Neck; 2018 Nov; 40(11):2546-2557. PubMed ID: 29761587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil to Lymphocyte Ratio as Predictor of Treatment Response in Esophageal Squamous Cell Cancer.
    Barbetta A; Nobel TB; Sihag S; Hsu M; Tan KS; Bains MS; Isbell JM; Janjigian YY; Wu AJ; Bott MJ; Jones DR; Molena D
    Ann Thorac Surg; 2018 Sep; 106(3):864-871. PubMed ID: 29738752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.
    Gandhi AK; Roy S; Biswas A; Raza MW; Saxena T; Bhasker S; Sharma A; Thakar A; Mohanti BK
    Auris Nasus Larynx; 2016 Feb; 43(1):45-9. PubMed ID: 26165629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of excision repair cross-complementation group1 in objective response after cisplatin-based concurrent chemoradiotherapy and survival in head and neck cancers: a systematic review and meta-analysis.
    Gao Y; Liu D
    Oral Oncol; 2015 Jun; 51(6):570-7. PubMed ID: 25857670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia and neutrophil-to-lymphocyte ratio are prognostic in p16-positive oropharyngeal carcinoma treated with concurrent chemoradiation.
    Gorphe P; Chekkoury Idrissi Y; Tao Y; Schernberg A; Ou D; Temam S; Casiraghi O; Blanchard P; Mirghani H
    Papillomavirus Res; 2018 Jun; 5():32-37. PubMed ID: 29253748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma.
    Xiao Q; Zhang B; Deng X; Wu J; Wang H; Wang Y; Wang W
    PLoS One; 2016; 11(12):e0168299. PubMed ID: 27959959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.